Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Cefuroxime axetil
Drug ID BADD_D00408
Description Broad-spectrum cephalosporin antibiotic resistant to beta-lactamase. It has been proposed for infections with gram-negative and gram-positive organisms, gonorrhea, and haemophilus.
Indications and Usage For the treatment of many different types of bacterial infections such as bronchitis, sinusitis, tonsillitis, ear infections, skin infections, gonorrhea, and urinary tract infections.
Marketing Status Prescription; Discontinued
ATC Code J01DC02; S01AA27
DrugBank ID DB01112
KEGG ID D00914
MeSH ID C040738
PubChem ID 5361467
TTD Drug ID Not Available
NDC Product Code 67877-216; 65862-700; 64679-920; 65862-699; 65862-505; 60429-657; 61788-1000; 16714-400; 65862-339; 50090-0781; 57237-058; 70518-2694; 64679-921; 43063-584; 65862-698; 64679-922; 57237-059; 63187-991; 61919-044; 68180-303; 61919-747; 43063-656; 70934-088; 70518-3215; 43063-623; 50090-4153; 51407-334; 60687-272; 50090-2157; 50090-2159; 72789-035; 16714-401; 68071-1637; 50090-2158; 51407-333; 68180-302; 53002-2670; 43063-657; 68071-4947; 53002-2750; 60429-656; 55289-385; 67877-215
Synonyms cefuroxime axetil | acetoxyethylcefuroxime | cefuroxime 1-acetoxyethyl ester | Ceftin | Zinnat | CCI 15641 | CCI-15641
Chemical Information
Molecular Formula C20H22N4O10S
CAS Registry Number 64544-07-6
SMILES CC(OC(=O)C)OC(=O)C1=C(CSC2N1C(=O)C2NC(=O)C(=NOC)C3=CC=CO3)COC(=O)N
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Sinusitis22.07.03.007; 11.01.13.005--
Somnolence19.02.05.003; 17.02.04.006--
Stevens-Johnson syndrome11.07.01.005; 10.01.03.020; 23.03.01.007; 12.03.01.014--
Stomatitis07.05.06.005--
Swollen tongue23.04.01.014; 07.14.02.003; 10.01.05.015--Not Available
Tachycardia02.03.02.007--Not Available
Thirst14.03.02.007; 08.01.09.021--Not Available
Thrombocytopenia01.08.01.002--Not Available
Toxic epidermal necrolysis23.03.01.008; 12.03.01.015; 11.07.01.006; 10.01.01.006--
Trismus17.01.03.004; 15.05.04.004--
Upper respiratory tract infection22.07.03.011; 11.01.13.009--
Urethral pain20.02.02.014--Not Available
Urine glucose false positive13.02.02.006--Not Available
Urticaria23.04.02.001; 10.01.06.001--
Vaginal discharge21.08.02.002--
Vaginal infection21.14.02.002; 11.01.10.002--
Vaginal inflammation21.14.02.001--
Vomiting07.01.07.003--
Vulvovaginal candidiasis21.14.02.003; 11.03.03.005--Not Available
Vulvovaginal discomfort21.08.02.005--Not Available
Urethral haemorrhage24.07.03.006; 20.07.01.003--Not Available
Muscle tightness15.05.03.007--Not Available
Musculoskeletal stiffness15.03.01.005--Not Available
Musculoskeletal discomfort15.03.04.001--Not Available
Haemorrhage24.07.01.002--Not Available
Vulvovaginal pruritus23.03.12.009; 21.08.02.004--Not Available
Blood alkaline phosphatase increased13.04.02.004--
Hepatic enzyme increased13.03.01.019--Not Available
Coombs test positive13.01.01.002--Not Available
Decreased appetite14.03.01.005; 08.01.09.028--
The 3th Page    First    Pre   3 4    Next   Last    Total 4 Pages